For the current REF see the REF 2021 website REF 2021 logo

Output details

2 - Public Health, Health Services and Primary Care

University of Exeter

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.

Type
D - Journal article
Title of journal
Health Technol Assess
Article number
-
Volume number
16
Issue number
42
First page of article
iii
ISSN of journal
1366-5278
Year of publication
2012
URL
-
Number of additional authors
11
Additional information

a. The author made a substantial contribution

to the conception and design of the study;

to the organisation of the conduct of the study;

to carrying out the study (including

acquisition of study data); and to analysis and

interpretation of study data.

and

b. The author helped draft the output; and critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
1 - Health Services Research
Citation count
5
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-